Neuren Pharmaceuticals Limited (AU:NEU)
ASX:NEU
Holding AU:NEU?
Track your performance easily

Neuren Pharmaceuticals Limited (NEU) Income Statement

159 Followers

Neuren Pharmaceuticals Limited Income Statement

Last quarter (Q4 2022), Neuren Pharmaceuticals Limited's total revenue was AU$―, a decrease of ― from the same quarter last year. In Q4, Neuren Pharmaceuticals Limited's net income was AU$―. See Neuren Pharmaceuticals Limited’s key income statements, including revenue, expenses, profit, and income.
Income Statement
TTM
Dec 22Dec 21Dec 20Dec 19Dec 18
Total Revenue
-AU$ 14.55M----
Cost of Revenue
------
Gross Profit
-AU$ 14.55M----
Operating Expense
-AU$ 16.16MAU$ 11.44MAU$ 9.53MAU$ 11.57MAU$ 8.18M
Operating Income
-AU$ -1.61MAU$ -11.44MAU$ -9.53MAU$ -11.57MAU$ -8.18M
Net Non Operating Interest Income Expense
-AU$ 391.00KAU$ 41.00KAU$ 147.00KAU$ 389.00KAU$ 218.00K
Other Income Expense
-AU$ 1.39MAU$ 3.60MAU$ 186.00KAU$ 366.00KAU$ 11.03M
Pretax Income
-AU$ 184.00KAU$ -7.79MAU$ -9.19MAU$ -10.82MAU$ 3.07M
Tax Provision
-AU$ 0.00AU$ 0.00AU$ 0.00AU$ 0.00AU$ 0.00
Earnings From Equity Interest Net Of Tax
------
Net Income Common Stockholders
-AU$ 184.00KAU$ -7.79MAU$ -9.19MAU$ -10.82MAU$ 3.07M
Basic EPS
-AU$ <0.01AU$ -0.07AU$ -0.09AU$ -0.11AU$ 0.03
Diluted EPS
-AU$ <0.01AU$ -0.07AU$ -0.09AU$ -0.11AU$ 0.03
Basic Average Shares
-AU$ 125.97MAU$ 117.77MAU$ 107.06MAU$ 100.17MAU$ 99.04M
Diluted Average Shares
-AU$ 125.97MAU$ 117.77MAU$ 107.06MAU$ 100.17MAU$ 99.04M
Dividend Per Share
------
Total Operating Income As Reported
------
Reported Normalized Basic E P S
------
Reported Normalized Diluted E P S
------
Rent Expense Supplemental
------
Total Expenses
------
Net Income From Continuing And Discontinued Operation
-AU$ 184.00KAU$ -7.79MAU$ -9.19MAU$ -10.82MAU$ 3.07M
Normalized Income
-AU$ 184.00KAU$ -7.79MAU$ -9.19MAU$ -10.82MAU$ 3.07M
Interest Expense
------
EBIT
-AU$ -1.61MAU$ -11.44MAU$ -9.53MAU$ -11.57MAU$ -8.18M
EBITDA
-AU$ -1.60MAU$ -11.43MAU$ -9.53MAU$ -11.57MAU$ -8.18M
Currency in AUD

Neuren Pharmaceuticals Limited Earnings and Revenue History

What am I Missing?
Make informed decisions based on Top Analysts' activity
Know what industry insiders are buying
Get actionable alerts from top Wall Street Analysts
Find out before anyone else which stock is going to shoot up
Get powerful stock screeners & detailed portfolio analysis